Keyphrases
Lupus
100%
New Therapies
100%
Belimumab
100%
Mouse Model
50%
Interferon-α (IFN-α)
50%
Attenuation
50%
FDA-approved Drugs
50%
Clinical Manifestations
50%
Systemic Lupus Erythematosus
50%
Targeted Therapy
50%
Rituximab
50%
Drug Development
50%
Therapeutic Modalities
50%
Mycophenolate Mofetil
50%
Systemic Autoimmune Diseases
50%
Potential Therapy
50%
Translational Studies
50%
Immune Parameters
50%
Organ Involvement
50%
Biological Drugs
50%
Murine Studies
50%
Immunoregulatory Factors
50%
Organ Toxicity
50%
Abatacept
50%
Medicine and Dentistry
Systemic Lupus Erythematosus
100%
Lupus Erythematosus
100%
Belimumab
20%
Interferon
10%
Targeted Therapy
10%
Weakness
10%
Cell Population
10%
Therapeutic Modality
10%
Rituximab
10%
Mycophenolic Acid
10%
Immunocompetent Cell
10%
Abatacept
10%
Systemic Autoimmune Disease
10%
Immunology and Microbiology
Lupus Erythematosus
100%
Systemic Lupus Erythematosus
100%
Belimumab
20%
Mouse Model
10%
interferon
10%
Immunocompetent Cell
10%
Cell Population
10%
Rituximab
10%
Systemic Autoimmune Disease
10%
Mycophenolic Acid
10%
Abatacept
10%
Pharmacology, Toxicology and Pharmaceutical Science
Systemic Lupus Erythematosus
100%
Belimumab
20%
Interferon
10%
Mouse Model
10%
Rituximab
10%
Drug Development
10%
Weakness
10%
Mycophenolic Acid
10%
Autoimmune Disease
10%
Abatacept
10%
Biochemistry, Genetics and Molecular Biology